← Human Trials & Peer-Reviewed Studies
Does glutathione flush reduce acute cellular rejection in liver allografts?
Plain-language guide to PMID 9649799 (1998): randomized controlled trial study of Glutathione, cellulite.
Key Facts
- PMID
- 9649799
- Journal
- Biochemical Society transactions
- Year
- 1998
- Study type
- Randomized Controlled Trial
- Authors
- el-Wahsh M et al. (7 authors)
- DOI
- 10.1042/bst026s124
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial paper looks at Glutathione in the context of cellulite.
PubMed holds no abstract for it, so this summary is built from its title ("Does glutathione flush reduce acute cellular rejection in liver allografts?") and its index terms.
How the Study Was Run
The design is described as randomized.
Random assignment meant chance, not the researchers, decided who got Glutathione and who got the comparison, which limits bias.
What Was Measured
The subject headings attached to it are Glutathione, Graft Rejection, Liver Transplantation and Transplantation, Homologous.
What This Means in Plain Language
The paper is a randomized study of Glutathione in people with cellulite.
The publication is from 1998 (Biochemical Society transactions), a journal based in England.
More context: the Glutathione compound page, Cellulite research.
Our Notes on the Compound
Glutathione: The body's main antioxidant.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.